Position in NRIX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$507,276
-$7,960,327 QoQ
Shares Held
20,910
-96.2% QoQ
Ownership
0.020%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#124
of 210 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NRIX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026MILLENNIUM MANAGEMENT LLC holds $4,596,705,485 across 322 Biotechnology names. NRIX ranks #268 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
468,410 | $232,673,299 | |
| 2 | INSM |
INSMED Inc
|
2,048,005 | $218,358,293 | |
| 3 | APGE |
Apogee Therapeutics, Inc.
|
1,491,404 | $197,954,052 | |
| 4 | JAZZ |
Jazz Pharmaceuticals plc
|
763,880 | $184,072,163 | |
| 5 | ONC |
BeOne Medicines Ltd.
|
543,323 | $154,830,755 | |
| 6 | AXSM |
Axsome Therapeutics, Inc.
|
556,088 | $136,113,659 | |
| 7 | BMRN |
Biomarin Pharmaceutical Inc
|
2,071,816 | $118,549,311 | |
| 8 | REGN |
Regeneron Pharmaceuticals, Inc.
|
165,120 | $102,958,924 |
All Filings in NRIX
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $507,276 | 20,910 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $8,467,603 | 546,297 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $3,410,028 | 179,759 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $14,081,381 | 1,523,959 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $10,564,885 | 927,558 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $10,387,860 | 874,399 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $7,990,741 | 424,137 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $4,982,003 | 221,718 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $12,514,132 | 599,623 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $5,501,460 | 374,249 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $3,896,708 | 377,588 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $2,264,914 | 288,157 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $6,437,665 | 644,411 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $4,098,936 | 461,592 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $6,009,738 | 547,335 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $9,641,222 | 739,925 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $10,287,127 | 811,928 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $5,130,910 | 366,232 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $17,262,479 | 596,286 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $7,097,014 | 236,883 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $11,301,408 | 425,986 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $7,459,579 | 239,935 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $3,722,147 | 113,204 | Shares | Sole | 2021-02-16 | |
| No filing history on record for this holder in this stock. | ||||||